قالب وردپرس درنا توس
Home / Business / Contract manufacturer Catalent will increase the production rate of Moderna Covid-19 vaccine

Contract manufacturer Catalent will increase the production rate of Moderna Covid-19 vaccine



Contract drug manufacturer Catalent Inc. is expanding Moderna Inc.’s progress in the production of Covid-19 vaccines in the United States. This development can ensure that the United States has sufficient supplies while increasing the number of vaccines.

People familiar with the matter said that Catalent has reached an agreement with Moderna that will increase the rate of vaccine production at the contract manufacturer’s plant in Bloomington, Indiana, to about 400 bottles per minute this month.

Catalent will shift the production of injections from two slower production lines to a faster production line. People familiar with the matter said that the new agent will start shipping next month, and the upgraded factory will be able to refill 80 million bottles a year.

The expansion will help Moderna achieve its goal of providing another 1

00 million doses to the United States by the end of May and another 100 million doses by the end of July.

In recent weeks, as manufacturers have expanded their production lines and adopted other measures to increase production, the production rate of several licensed vaccines in the United States has increased.


Source link